Plureon
Plureon has been creating technologies for regenerative medicine since 2002. Headquartered in Winston-Salem, North Carolina, the company collaborates to develop innovative solutions for the regenerative medicine market. It focuses on developing technology platforms based on pluripotent stem cells extracted from birth tissues, which may be used in regenerative medicine and other therapies.
Industries
biotechnology
consulting
health-diagnostics
Nr. of Employees
small (1-50)
Plureon
Winston Salem, North Carolina, United States, North America
Products
Technology platforms based on birth-tissue-derived pluripotent stem cells
Technology platforms built around pluripotent stem cells extracted from birth tissues, intended for application in regenerative medicine and related therapeutic research.
Technology platforms based on birth-tissue-derived pluripotent stem cells
Technology platforms built around pluripotent stem cells extracted from birth tissues, intended for application in regenerative medicine and related therapeutic research.
Services
Technology development services for regenerative medicine
Collaborative technical development support to advance regenerative-medicine-focused technologies and platforms.
Technology development services for regenerative medicine
Collaborative technical development support to advance regenerative-medicine-focused technologies and platforms.
Expertise Areas
- Regenerative medicine platform development
- Pluripotent stem cell research
- Cell therapy and tissue engineering
- Collaborative technology development for life sciences
Key Technologies
- Pluripotent stem cell platforms (birth-tissue-derived)
- Cell therapy methods
- Tissue engineering
- Regenerative medicine technology development